絞り込み

16532

広告

Systematic review with meta-analysis: Vonoprazan, a potent acid blocker, is superior to proton-pump inhibitors for eradication of clarithromycin-resistant strains of Helicobacter pylori.

著者 Li M , Oshima T , Horikawa T , Tozawa K , Tomita T , Fukui H , Watari J , Miwa H
Helicobacter.2018 Jun 06 ; ():e12495.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (58view , 0users)

Full Text Sources

Vonoprazan is a novel gastric acid suppressant that is applied in Japan to treat gastric diseases including Helicobacter pylori (H. pylori) infection. This meta-analysis aimed to summarize the ability of vonoprazan to eradicate clarithromycin-susceptible and clarithromycin-resistant H. pylori strains.
PMID: 29873436 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード